| Trial Identifier: | D3250R00113 |
| Sponsor: | AstraZeneca |
| Start Date: | February 2023 |
| Primary Completion Date: | April 2025 |
| Study Completion Date: | April 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Colombia | Bogota, Colombia |
| Colombia | Bucaramanga, Colombia |
| Colombia | Ibague, Colombia |
| Colombia | Pereira, Colombia |
| Dominican Republic | Santiago, Dominican Republic |
| Dominican Republic | Santo Domingo, Dominican Republic |
| India | Ahmedabad, India |
| India | Ajmer, India |
| India | Chennai, India |
| India | Delhi, India |
| India | Hyderabad, India |
| India | Jaipur, India |
| India | Kolkata, India |
| India | Pune, India |
| India | Secundrabad, India |
| India | Vadodara, India |
| Kuwait | Sabah Al Salem, Kuwait |
| Oman | Muscat, Oman |
| Qatar | Doha, Qatar |
| Saudi Arabia | Jeddah, Saudi Arabia |
| Saudi Arabia | Riyadh, Saudi Arabia |
| United Arab Emirates | Abu Dhabi, United Arab Emirates |
| United Arab Emirates | Al Ain, United Arab Emirates |
| United Arab Emirates | Dubai, United Arab Emirates |